146 related articles for article (PubMed ID: 9838468)
21. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
22. Case report: anti-proteinase 3 antibody activity in a patient with primary sclerosing cholangitis: clinical remission following ursodeoxycholic acid therapy.
Wong SS; Lawton JW
J Gastroenterol Hepatol; 1996 Dec; 11(12):1161-3. PubMed ID: 9034936
[TBL] [Abstract][Full Text] [Related]
23. A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
Suskind DL; Finn L; Wahbeh G; Christie D; Horslen S
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):542-4. PubMed ID: 17033534
[No Abstract] [Full Text] [Related]
24. [A 67 year-old man consults for icterus].
Couchard AC; Panis Y
J Chir (Paris); 2002 Jun; 139(3):166-70. PubMed ID: 12391669
[No Abstract] [Full Text] [Related]
25. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
[No Abstract] [Full Text] [Related]
26. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
27. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Holtmeier J; Leuschner U
Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
[TBL] [Abstract][Full Text] [Related]
28. Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis.
Lebovics E; Salama M; Elhosseiny A; Rosenthal WS
Gastroenterology; 1992 Jun; 102(6):2143-7. PubMed ID: 1587436
[TBL] [Abstract][Full Text] [Related]
29. Complete resolution of extensive xanthomas associated with primary sclerosing cholangitis following liver transplantation.
Ghadiri SJ; Gunputh P; Poyner EFM; Carmichael AJ
Clin Exp Dermatol; 2017 Dec; 42(8):927-928. PubMed ID: 28940652
[No Abstract] [Full Text] [Related]
30. URSO not so good for PSC.
Petruff CA
Inflamm Bowel Dis; 1998 May; 4(2):172-3. PubMed ID: 9589304
[No Abstract] [Full Text] [Related]
31. [State-of-the-art therapy for primary sclerosing cholangitis].
Wanger S; Meier PN; Maschek H; Nashan B; Manns MP
Dtsch Med Wochenschr; 1998 Mar; 123(11):325-7. PubMed ID: 9540772
[No Abstract] [Full Text] [Related]
32. Management of primary sclerosing cholangitis: conventions and controversies.
Chandok N; Hirschfield GM
Can J Gastroenterol; 2012 May; 26(5):261-8. PubMed ID: 22590699
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period.
De Maria N; Colantoni A; Rosenbloom E; Van Thiel DH
Hepatogastroenterology; 1996; 43(12):1472-9. PubMed ID: 8975951
[TBL] [Abstract][Full Text] [Related]
34. [Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid].
Christensen KL; Andersen BN; Vilstrup H
Ugeskr Laeger; 1997 Nov; 159(48):7151-3. PubMed ID: 9417723
[TBL] [Abstract][Full Text] [Related]
35. Primary sclerosing cholangitis.
Geonzon-Gonzales MR
Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
[TBL] [Abstract][Full Text] [Related]
36. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
[TBL] [Abstract][Full Text] [Related]
37. Ursodiol for all?
Lee SD; Surawicz CM
Am J Gastroenterol; 2001 Dec; 96(12):3437-8. PubMed ID: 11774966
[No Abstract] [Full Text] [Related]
38. The medical management of primary sclerosing cholangitis.
Cullen SN; Chapman RW
Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
[TBL] [Abstract][Full Text] [Related]
39. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
Charatcharoenwitthaya P; Angulo P; Enders FB; Lindor KD
Hepatology; 2008 Jan; 47(1):133-42. PubMed ID: 17992695
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Severe Hypercholesterolemia in a Woman With Advanced Primary Sclerosing Cholangitis.
Xiao C; Hegele RA; Lewis GF
JAMA Cardiol; 2017 May; 2(5):575-576. PubMed ID: 28384790
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
